Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Nov 1;36(13):1783-1789.
doi: 10.1097/QAD.0000000000003283. Epub 2022 Jun 22.

The effect of an HIV preexposure prophylaxis panel management strategy to increase preexposure prophylaxis prescriptions

Parya Saberi  1 , Marie C D Stoner  2 , Kristin Ming  1 , Nadra E Lisha  3 , J Carlo Hojilla  4 , Hyman M Scott  5 , Albert Y Liu  5 , Wayne T Steward  1 , Mallory O Johnson  1 , Torsten B Neilands  1
Affiliations
Randomized Controlled Trial

The effect of an HIV preexposure prophylaxis panel management strategy to increase preexposure prophylaxis prescriptions

Parya Saberi et al. AIDS. .

Abstract

Objective: The HIV preexposure prophylaxis optimization intervention (PrEP-OI) study evaluated the efficacy of a panel management intervention using PrEP coordinators and a web-based panel management tool to support healthcare providers in optimizing PrEP prescription and ongoing PrEP care.

Design: The PrEP-OI study was a stepped-wedge randomized clinical trial conducted across 10 San Francisco Department of Public Health primary care sites between November 2018 and September 2019. Each month, clinics one-by-one initiated PrEP-OI in random order until all sites received the intervention by the study team.

Methods: The primary outcome was the number of PrEP prescriptions per month. Secondary outcomes compared pre- and postintervention periods on whether PrEP was discussed and whether PrEP-related counseling (e.g., HIV risk assessment, risk reduction counseling, PrEP initiation/continuation assessment) was conducted. Prescription and clinical data were abstracted from the electronic health records. We calculated incidence rate ratios (IRR) and risk ratios (RR) to estimate the intervention effect on primary and secondary outcomes.

Results: The number of PrEP prescriptions across clinics increased from 1.85/month (standard deviation [SD] = 2.55) preintervention to 2.44/month (SD = 3.44) postintervention (IRR = 1.34; 95% confidence interval [CI] = 1.05-1.73; P = 0.021). PrEP-related discussions during clinic visits (RR = 1.13; 95% CI = 1.04-1.22; P = 0.004), HIV risk assessment (RR = 1.40; 95% CI = 1.14-1.72; P = 0.001), and risk reduction counseling (RR = 1.16; 95% CI = 1.03-1.30; P = 0.011) increased from the pre- to the postintervention period. Assessment of PrEP initiation/continuation increased over time during the postintervention period (RR = 1.05; 95% CI = 0.99-1.11; P = 0.100).

Conclusions: A panel management intervention using PrEP coordinators and a web-based panel management tool increased PrEP prescribing and improved PrEP-related counseling in safety-net primary care clinics.

PubMed Disclaimer

References

    1. Centers for Disease Control and Prevention. HIV in the United States and Dependent Areas. In. Atlanta, GA; 2021.
    1. Centers for Disease Control and Prevention. 2019 National HIV Surveillance System Reports. In; 2021.
    1. Blumenthal J, Jain S, Krakower D, Sun X, Young J, Mayer K, et al. Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP. Aids Behav 2015; 19(5):802–810. - PMC - PubMed
    1. Karris MY, Beekmann SE, Mehta SR, Anderson CM, Polgreen PM. Are We Prepped for Preexposure Prophylaxis (PrEP)? Provider Opinions on the Real-World Use of PrEP in the United States and Canada. Clin Infect Dis 2014; 58(5):704–712. - PMC - PubMed
    1. Cohen SE, Liu AY, Bernstein KT, Philip S. Preparing for HIV Pre-Exposure Prophylaxis Lessons Learned from Post-Exposure Prophylaxis. American journal of preventive medicine 2013; 44(1):S80–S85. - PMC - PubMed

Publication types

Substances